Depreciation in USD of BIORA THERAPEUTICS, INC. from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BIORA THERAPEUTICS, INC. quarterly and annual Depreciation history and change rate from Q2 2019 to Q3 2024.
  • BIORA THERAPEUTICS, INC. Depreciation for the quarter ending 30 Sep 2024 was $100,000, unchanged year-over-year.
  • BIORA THERAPEUTICS, INC. annual Depreciation for 2023 was $600,000, a 33% decline from 2022.
  • BIORA THERAPEUTICS, INC. annual Depreciation for 2022 was $900,000, a 36% decline from 2021.
  • BIORA THERAPEUTICS, INC. annual Depreciation for 2021 was $1,400,000, unchanged from 2020.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BIORA THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $100,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $100,000 -$100,000 -50% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q4 2023 $600,000 $200,000 $0 0% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $600,000 $100,000 -$100,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $700,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $700,000 $100,000 -$200,000 -67% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $900,000 $200,000 -$100,000 -33% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $1,000,000 $200,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $1,000,000 $200,000 -$300,000 -60% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $1,300,000 $300,000 -$100,000 -25% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $1,400,000 $300,000 +$1,300,000 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $100,000 $200,000 -$200,000 -50% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $300,000 $500,000 -$500,000 -50% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $800,000 $400,000 -$600,000 -60% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $1,400,000 $1,000,000 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $400,000 -$500,000 -56% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,000,000 +$100,000 +11% 01 Apr 2020 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $1,000,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 $900,000 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $900,000 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2

BIORA THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $600,000 -$300,000 -33% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $900,000 -$500,000 -36% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $1,400,000 $0 0% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,400,000 -$2,300,000 -62% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022 2021 FY
2019 $3,700,000 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.